10-Q/APeriod: Q2 FY2011

CENTENE CORP Quarterly Report (Amendment) for Q2 Ended Jun 30, 2011

Filed October 28, 2011For Securities:CNC

Summary

Centene Corporation's (CNC) 10-Q filing for the period ending October 28, 2011, reveals the company is actively managing its contractual relationships and financial obligations. Key exhibits include significant amendments to contracts with the Georgia Department of Community Health and the Texas Health and Human Services Commission, indicating ongoing operational adjustments and potential growth in these state-based programs. The inclusion of the Indenture for its 5.75% Senior Notes due 2017 highlights the company's use of debt financing to support its strategic objectives. Investors should note the company's focus on compliance and financial reporting, as evidenced by the inclusion of the computation of its ratio of earnings to fixed charges. While this filing primarily details contractual agreements and financial structures, it underscores Centene's engagement with government healthcare programs and its established debt instruments, which are crucial components of its operational and financial landscape.

Financial Statements
Beta
Revenue$1.32B
Operating Expenses$1.26B
Operating Income$55.30M
Interest Expense$5.26M
Net Income$28.37M
EPS (Basic)$0.14
EPS (Diluted)$0.14
Shares Outstanding (Basic)200.67M
Shares Outstanding (Diluted)209.96M

Key Highlights

  • 1Company entered into an Indenture for 5.75% Senior Notes due 2017, indicating debt financing.
  • 2Amendment #10 to Contract No. 0653 with Georgia Department of Community Health filed.
  • 3Amendment S (Version 1.18.1) to Contract with Texas Health and Human Services Commission filed.
  • 4Computation of ratio of earnings to fixed charges included as an exhibit.
  • 5Exhibits showcase ongoing contractual relationships with state health programs.
  • 6The filing includes various contractual amendments and financial documentation.

Frequently Asked Questions

The 5.75% Senior Notes due 2017 represent a significant debt obligation for Centene. Investors should review the terms of the Indenture to understand the company's leverage, interest payment obligations, and any covenants that may affect future operations or financial flexibility.

These amendments suggest that Centene is actively engaged in refining its agreements with state health authorities. Such changes can impact revenue streams, service responsibilities, and profitability related to these government-sponsored programs. Investors should look for further details on the nature and impact of these amendments in other sections of the filing or subsequent reports.

This exhibit is a standard financial disclosure that demonstrates Centene's ability to cover its fixed financing charges (like interest payments) with its earnings. A healthy ratio generally indicates a lower financial risk for the company and its debtholders.

This specific 'Other Information' section primarily focuses on exhibits, which include contractual agreements and financial calculations. It does not typically contain detailed financial performance metrics or segment information; those are usually found in the 'Financial Statements' and 'Management's Discussion and Analysis' sections of the 10-Q.